
A tumor that develops in the nasal cavity is called olfactory neuroblastoma, also known as esthesioneuroblastoma. The sensation of smell is produced by neurons and other tissue in the nasal cavity. This kind of tumor begins in the nasal cavity and can grow into the nearby eyes and brain. Olfactory neuroblastoma can potentially extend to other regions of the body, including the neck, lungs, and bones.
The following warning signs and symptoms could be markers of olfactory neuroblastoma. Watery eyes, nosebleeds, congestion or stuffiness that worsens or persists, nose obstruction, postnasal drip, or nasal discharge in the throat, and eye pain, pus from the nose, numbness in the face or teeth, loose teeth, diminished smell, or changes in eyesight, • Problem opening the mouth; • Pain or pressure in the ears; • Enlarged neck lymph nodes
Symptoms of olfactory neuroblastoma include:
Causes
The precise cause of olfactory neuroblastoma has not been determined by experts. Generally speaking, DNA alterations in cells cause cancer. The instructions that inform a cell what to do are encoded in its DNA. The modifications instruct the cells to rapidly produce a large number of new cells. When healthy cells would normally die, the alterations allow the cells to survive. Too many cells are produced as a result.
The cells may accumulate into a mass known as a tumor. Healthy body tissue may be invaded and destroyed by the tumor as it grows. Cells may eventually separate and disperse throughout the body.
Risk Factors
It is thought to be a major risk factor to work in areas where one is exposed to wood dust, metal dusts (nickel, cadmium), wheat, glues, formaldehyde, and other solvents. Olfactory neuroblastoma risk may also be raised by exposure to tobacco smoke.
Complications
The complications of Olfactory Neuroblastoma include:
In Malaysia Improved surgical methods, radiation treatments like proton beam therapy (PBT) and intensity-modulated radiation therapy (IMRT), and new chemotherapy regimens are all helping to treat olfactory neuroblastoma (ONB) . For more severe instances, chemotherapy—which frequently uses platinum-based agents—is employed, and immunotherapy options, including as PD-L1 inhibitors, are being investigated. Sunway Cancer Centre and other advanced treatment facilities provide state-of-the-art technologies to improve patient results. For ONB patients in Malaysia, these advancements are improving their prognosis and quality of life.
Although the precise origin of olfactory neuroblastoma is unknown, evidence points to a possible connection with chemical exposure. According to research, People exposed to dangerous chemicals and particles at work or through other activities are more likely to develop malignancies of the nasal cavity. Wood dust, wheat, glues, nickel and cadmium dust, formaldehyde, and other solvents are a few potential offenders. The development of an olfactory neuroblastoma may be influenced by tobacco smoke. Steer clear of these chemicals as much as you can to protect yourself.
Chemotherapy: Chemotherapy may be used in situations when the tumour has migrated to other body areas. The most often prescribed chemotherapeutic medications for neuroblastoma include vincristine, carboplatin, doxorubicin, cyclophosphamide, and cisplatin .Typically, chemotherapy is a systemic treatment. This implies that the medications enter the bloodstream and travel throughout the body to kill cancer cells, including ones that may have separated from the main tumour. The medications can be administered intravenously (IV) or orally. The medications may occasionally be administered safely using a specialised tool known as a central venous catheter. When chemotherapy begins, it is often implanted during surgery and kept there until the end of the course of treatment.
Cost Start From USD 1500 - USD 3500Explore Options
Radiation therapy: Some olfactory neuroblastoma tumours may be treated with radiation therapy. Radiation therapy may be used as the primary treatment or to help lower the likelihood of tumour recurrence following surgery. The success rates for radiation therapy are 90–95% in stage I, 85–90% in stage II, and 75–80% in stage III. The patient is recommended to see the doctor for follow-up every three months following radiation therapy.
Olfactory neuroblastoma is diagnosed by examining the nasal cavity using various scanning techniques. These consist of MRIS, CT scans, and X-rays. A physician may perform a biopsy to obtain further information. A tissue sample is taken and examined under a microscope to ascertain the type of cancer present.
Since neuroblastoma occurs near essential structures, patients may require rehab for the following reasons.
Patients may experience changes in their sense of smell due to the tumour's proximity to the olfactory nerves, necessitating olfactory training or adaptation techniques. Dryness in the nasal passages is one of the adverse effects of radiation therapy that may require the adoption of extra management techniques. Exercises to enhance the function of the muscles of the face, control pain, and encourage the repair of soft tissues. Addressing any speech issues that can result from disrupting the surrounding structures after surgery. Activities that aid in retraining the sense of smell, if it has been severely compromised. Advice on controlling nutritional requirements in light of possible swallowing issues
The only treatment options are surgery, radiation therapy, and chemotherapy. The most often prescribed chemotherapeutic medications for neuroblastoma include vincristine, carboplatin, doxorubicin, cyclophosphamide, and cisplatin.









Kuala Lumpur, Malaysia
Sunway Medical Centre has initiated a comprehensive expansion plan close to its current hospital facility to enhance its ability to provide services to the global market. The new Cancer Radiosurgery Center and Nuclear Medicine Center, which will also house additional Centers of Excellence like the Digestive Health Center and Dialysis Center, marked the completion of Tower C's first phase in October 2016.

Kuala Lumpur, Malaysia
Prince Court is a private medical facility in the center of Kuala Lumpur that has 277 individual beds. Our dedication is to provide you with the best treatment possible from the time you arrive until you depart, healthier and happier. We are well-known for our top-notch facilities, cutting-edge technology, and friendly customer service.

Kuala Lumpur, Malaysia
Subang Jaya Medical Center is renowned for pioneering radiation oncology treatments and infrastructure in Malaysia. The hospital also has a state-of-the-art Cancer Radiosurgery Centre (CRC), which is fully furnished with the latest medical technology for cancer detection, monitoring, and treatment.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing Malaysia:
Due to advancements in medical facilities, such as minimally invasive surgical techniques.
Yes, a group of specialists, including radiation oncologists, neurosurgeons, and head and neck surgeons, collaborate to create a customised treatment plan for each patient. With treatment, the majority of patients with olfactory neuroblastoma recover.
In Malaysia, modern radiation (IMRT), interdisciplinary care, and minimally invasive endoscopic surgery are all very efficient ways to treat olfactory neuroblastoma (ON).
Yes, many Malaysian hospitals offer the following for olfactory neuroblastoma treatment:
Always consider the following factors when selecting a hospital in Malaysia:
The 5-year overall survival (OS) rates for olfactory neuroblastoma (ONB) range from 70% to 90%, according to international research, regardless of the lack of particular data on treatment success rates in Malaysia.
You need to keep an eye out for the following signs in them:
Patients with Olfactory Neuroblastoma may experience long-term consequences such as irreversible loss of smell (anosmia), changes in vision, cognitive impairment, and the possibility of spread of the tumour to other parts of the body.
You can see Malaysia's top neuro hospitals and doctors for a second opinion on Olfactory Neuroblastoma treatment. Numerous prestigious medical facilities consult with skilled doctors who will examine your diagnosis and suggest the best course of action. You can get support by speaking with a medical tourism facilitator at MediGence to select the best doctor and facility. It provides specialised rehabilitation programs.